FY2017 Appendix 4E and Financial Report
March 2, 2018
Imagion Biosystems Limited Appendix 4E for the year ended 31 December 2017 has been lodged with ASX under Listing Rule 4.3A. Download FY 2017 Appendix
Category: Investor updates
Imagion Biosystems Appoints Dr Farideh Bischoff as Vice President of Clinical Research
February 22, 2018
Cancer diagnostics industry veteran will lead first-in-human clinical trial program Imagion Biosystems is pleased to announce the appointment of Farideh Bischoff, PhD, as the company’s Vice
Notice of change of interests of substantial holder – IBX
February 12, 2018
Imagion Biosystems today announced “Notice of change of interests of substantial holder — IBX.” View Form 604 Notice of change of interests of substantial holder —
Appendix 3B – Quotation of shares released from escrow
February 12, 2018
Imagion Biosystems today announced “Appendix 3B – Quotation of shares released from escrow.” View Appendix 3B – Quotation of shares released from escrow.
Imagion Biosystems December 2017 Quarterly Update
January 31, 2018
In accord with ASX requirements, Imagion Biosystems’ 2017 quarterly update was lodged with the Australian Securities Exchange on 31 January 2018. The update includes Appendix
Release of shares from escrow
January 23, 2018
In accordance with Listing Rule 3.10A, Imagion Biosystems Limited (the Company) advises that 30,950,569 fully paid ordinary shares in the Company, which are unquoted and
Audio Recording of December 2017 Investor Update Call — Listen Here
December 13, 2017
The audio file of the December 2017 Investor Update call is now available. Listen here: Visitors wishing to follow along with the visuals can watch
December 2017 Investor Update Presentation Visuals
December 12, 2017
Click on image above or here to download presentation visuals for December 2017 investor update. (2MB pdf)
Investor Conference Call
December 6, 2017
Imagion Biosystems Limited (Imagion, ASX:IBX) invites shareholders and other interested parties to join CEO Robert Proulx for an update on the company’s progress and developments.
Appendix 4C for Q3 2017
October 31, 2017
In accord with ASX requirements, Imagion Biosystems has lodged “Appendix 4C, Quarterly report for entities subject to Listing Rule 4.7B” for the Quarter ended 30